AbbVie trumpets Skyrizi's resounding win against J&J's Stelara in...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 16, 2023 at 11:52: AM
via AbbVie already shared last month that its Skyrizi had trounced Johnson & Johnson’s rival biologic drug Stelara in Crohn’s disease. Now, detailed trial results show just how decisive Skyrizi’s win is.

article source
 

<



Similar threads

cafead
AstraZeneca steps out from Daiichi&#039;s shadow, posting data on in-house rivals to AbbVie and Pfizer ADCs
Replies
0
Views
14
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
UnitedHealth to remove AbbVie&#039;s Humira from some US drug reimbursement lists next year
Replies
0
Views
10
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AbbVie sues rival BeiGene over alleged theft of cancer therapy secrets
Replies
0
Views
24
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AbbVie&#039;s Ubrelvy wards off migraines when used in reaction to early warning signs: study
Replies
0
Views
19
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Cigna to remove AbbVie&#039;s Humira from some drug reimbursement lists next year
Replies
0
Views
12
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote